This inventor holds 1 USPTO granted patent. Top assignee: Reborna Biosciences, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Shunya Suzuki - Innovator in Spinal Muscular Atrophy Treatment
Introduction
Shunya Suzuki is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of medical research, particularly in the treatment of spinal muscular atrophy. His innovative work has led to the development of a unique therapeutic agent that holds promise for patients suffering from this condition.
Latest Patents
Shunya Suzuki holds 1 patent related to his research. His patent, titled "Substituted pyrazolo[1,5-a]pyrazines for spinal muscular atrophy," describes a prophylactic or therapeutic agent that includes a compound represented by a specific formula. This invention aims to provide effective treatment options for spinal muscular atrophy, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Shunya Suzuki has been associated with Reborna Biosciences, Inc., where he has been able to apply his expertise in developing innovative solutions for complex medical challenges. His work has not only contributed to the scientific community but has also had a direct impact on patient care.
Collaborations
Shunya Suzuki has collaborated with esteemed colleagues, including Koji Fuji and Takeshi Yamasaki. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the research process.
Conclusion
In summary, Shunya Suzuki is a dedicated inventor whose work in spinal muscular atrophy treatment exemplifies innovation in medical research. His contributions are paving the way for new therapeutic options that could significantly improve the lives of those affected by this condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile